M&A Deal Summary

Selvita Acquires PozLab

On March 27, 2024, Selvita acquired life science company PozLab

Acquisition Highlights
  • This is Selvita’s 2nd transaction in the Life Science sector.
  • This is Selvita’s 1st transaction in Poland.

M&A Deal Summary

Date 2024-03-27
Target PozLab
Sector Life Science
Buyer(s) Selvita
Deal Type Add-on Acquisition

Target

PozLab

Poznan, Poland
PozLab is a contract development and manufacturing organization (“CDMO”) offering expert drug product development services and small pilot plant capabilities. The company provides drug product services through dedicated analytical, formulation, and process development, followed by analytical and microbiological testing, including the analysis of APIs and excipients. PozLab is based in Poznan, Poland.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Selvita

Krakow, Poland

Category Company
Founded 2007
Sector Life Science
Employees387
Revenue 347M PLN (2023)
DESCRIPTION

Selvita is an integrated service company providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development. Selvita was founded in 2007 and is based in Krakow, Poland.


DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 1 of 1
Country (Poland) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-23 Fidelta

Zagreb, Croatia

Fidelta Ltd. is a drug discovery service company with core scientific competencies in inflammation, fibrosis, and anti-infectives. The scope of services provided by Fidelta is complementary to Selvita’s offerings and will enable Selvita to build a competitive advantage in business areas such as DMPK, in vivo pharmacology, and toxicology, as well as increase its scale of operations within medicinal chemistry and in vitro pharmacology. Fidelta is based in Zagreb, Croatia.

Buy €31M